z-logo
open-access-imgOpen Access
Etiotropic therapy of the new coronavirus infection. Expectations and realities. Part 2
Author(s) -
Olga Yu. Kuznetsova
Publication year - 2022
Publication title -
russian family doctor
Language(s) - English
Resource type - Journals
eISSN - 2713-2331
pISSN - 2072-1668
DOI - 10.17816/rfd108485
Subject(s) - ritonavir , coronavirus , medicine , drug , placebo , clinical trial , monoclonal antibody , virology , intensive care medicine , covid-19 , pharmacotherapy , randomized controlled trial , protease inhibitor (pharmacology) , drug trial , immunology , viral load , pharmacology , virus , alternative medicine , antibody , pathology , disease , antiretroviral therapy , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom